Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Other Income (Minority Interest) : ¥31 Mil (TTM As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Jilin Aodong Pharmaceutical Group Co Other Income (Minority Interest)?

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary. Jilin Aodong Pharmaceutical Group Co's Other Income (Minority Interest) for the three months ended in Mar. 2024 was ¥11 Mil. Its Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥31 Mil.

Jilin Aodong Pharmaceutical Group Co Other Income (Minority Interest) Historical Data

The historical data trend for Jilin Aodong Pharmaceutical Group Co's Other Income (Minority Interest) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jilin Aodong Pharmaceutical Group Co Other Income (Minority Interest) Chart

Jilin Aodong Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Minority Interest)

Get a 7-Day Free Trial

10.24

17.46

9.64

-20.21

15.54

Jilin Aodong Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Income (Minority Interest)	Get a 7-Day Free Trial															-4.68	13.98	-5.05	11.29	11.01

Jilin Aodong Pharmaceutical Group Co Other Income (Minority Interest) Calculation

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary.

Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥31 Mil.

Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Other Income (Minority Interest) Explanation

Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company. It is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jilin Aodong Pharmaceutical Group Co Ltd (SZSE:000623) » Definitions » Other Income (Minority Interest)

Traded in Other Exchanges

N/A

Address

No. 2158, Jidong Street, Dunhua, CHN, 133700

Website

http://www.jlaod.com

Jilin Aodong Pharmaceutical Group Co Ltd is engaged in manufacturing of pharmaceuticals. Its products include Anshen Bunao Liquid, Antelope Cough Syrup, Yangxue Yin Oral Liquid, Xinnao Shutong Capsule, Calf Spleen Extract Injection, Xuefu Zhuyu Oral Liquid, and others.

Executives

Guo Shu Qin	Directors, executives
Wang Zhen Yu	Directors, Directors, and Executives
Zhao Da Long	Director
Yang Kai	Directors, executives
Li Xiu Lin	Director
Zhang Shu Yuan	Directors, executives
Chen Yong Feng	Supervisors
Zhang Ming Jing	Supervisors
Li An Ning	Supervisors
Lin Xiao Lin	Executives
Ying Gang	Director
Guo Li	Supervisors
Xu Dong Lin	Supervisors
Zhu Yan	Directors, executives
Li Li Ping	Supervisors

Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Headlines

No Headlines